These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

194 related items for PubMed ID: 10084283

  • 1. Inherited disorders of iron metabolism.
    Födinger M, Sunder-Plassmann G.
    Kidney Int Suppl; 1999 Mar; 69():S22-34. PubMed ID: 10084283
    [Abstract] [Full Text] [Related]

  • 2. Association of porphyria cutanea tarda with hereditary hemochromatosis.
    Mehrany K, Drage LA, Brandhagen DJ, Pittelkow MR.
    J Am Acad Dermatol; 2004 Aug; 51(2):205-11. PubMed ID: 15280838
    [Abstract] [Full Text] [Related]

  • 3. High prevalence of the His63Asp HFE mutation in Italian patients with porphyria cutanea tarda.
    Sampietro M, Piperno A, Lupica L, Arosio C, Vergani A, Corbetta N, Malosio I, Mattioli M, Fracanzani AL, Cappellini MD, Fiorelli G, Fargion S.
    Hepatology; 1998 Jan; 27(1):181-4. PubMed ID: 9425935
    [Abstract] [Full Text] [Related]

  • 4. Porphyria cutanea tarda associated with Cys282Tyr mutation in HFE gene in hereditary hemochromatosis: a case report and review of the literature.
    Young LC.
    Cutis; 2007 Nov; 80(5):415-8. PubMed ID: 18189029
    [Abstract] [Full Text] [Related]

  • 5. Human leukocyte antigen haplotypes and HFE mutations in Spanish hereditary hemochromatosis and sporadic porphyria cutanea tarda.
    Gonzalez-Hevilla M, de Salamanca RE, Morales P, Martínez-Laso J, Fontanellas A, Castro MJ, Rojo R, Moscoso J, Zamora J, Serrano-Vela JI, Arnaiz-Villena A.
    J Gastroenterol Hepatol; 2005 Mar; 20(3):456-62. PubMed ID: 15740492
    [Abstract] [Full Text] [Related]

  • 6. Iron overload in porphyria cutanea tarda.
    Sampietro M, Fiorelli G, Fargion S.
    Haematologica; 1999 Mar; 84(3):248-53. PubMed ID: 10189391
    [Abstract] [Full Text] [Related]

  • 7. [Role of the hemochromatosis gene in prophyria cutanea tarda. Prospective study of 56 cases].
    Skowron F, Bérard F, Grézard P, Wolf F, Morel Y, Perrot H.
    Ann Dermatol Venereol; 2001 May; 128(5):600-4. PubMed ID: 11427792
    [Abstract] [Full Text] [Related]

  • 8. Non-HFE hepatic iron overload.
    Pietrangelo A, Caleffi A, Corradini E.
    Semin Liver Dis; 2011 Aug; 31(3):302-18. PubMed ID: 21901660
    [Abstract] [Full Text] [Related]

  • 9. Mutations of the hereditary hemochromatosis candidate gene HLA-H in porphyria cutanea tarda.
    Santos M, Clevers HC, Marx JJ.
    N Engl J Med; 1997 May 01; 336(18):1327-8. PubMed ID: 9132598
    [No Abstract] [Full Text] [Related]

  • 10. Increased frequency of the haemochromatosis Cys282Tyr mutation in sporadic porphyria cutanea tarda.
    Roberts AG, Whatley SD, Morgan RR, Worwood M, Elder GH.
    Lancet; 1997 Feb 01; 349(9048):321-3. PubMed ID: 9024376
    [Abstract] [Full Text] [Related]

  • 11. Denaturing gradient gel electrophoresis analysis of the hemochromatosis (HFE) gene: impact of HFE gene mutations on the manifestation of porphyria cutanea tarda.
    Christiansen L, Bygum A, Thomsen K, Brandrup F, Hørder M, Petersen NE.
    Clin Chem; 1999 Nov 01; 45(11):2025-6. PubMed ID: 10545080
    [No Abstract] [Full Text] [Related]

  • 12. Genes that modify the hemochromatosis phenotype in mice.
    Levy JE, Montross LK, Andrews NC.
    J Clin Invest; 2000 May 01; 105(9):1209-16. PubMed ID: 10791995
    [Abstract] [Full Text] [Related]

  • 13. [Progress in the study of molecular genetics of iron metabolism].
    Niitsu Y.
    Nihon Naika Gakkai Zasshi; 2000 Apr 10; 89(4):768-73. PubMed ID: 10876938
    [No Abstract] [Full Text] [Related]

  • 14. [59-year-old patient with cutaneous lesions and increased iron metabolism parameters].
    Mangold E, Diepolder H, Lohse P, Pape GR, Ritter MM.
    Internist (Berl); 2000 Oct 10; 41(10):1103-7. PubMed ID: 11084896
    [No Abstract] [Full Text] [Related]

  • 15. [Mutations of hemochromatosis gene in volunteer blood donors and Chilean porphyria cutanea tarda patients].
    Wolff CF, Armas RM, Frank J, Poblete PG.
    Medicina (B Aires); 2006 Oct 10; 66(5):421-6. PubMed ID: 17137171
    [Abstract] [Full Text] [Related]

  • 16. Iron overload: molecular clues to its cause.
    Kühn LC.
    Trends Biochem Sci; 1999 May 10; 24(5):164-6. PubMed ID: 10322426
    [No Abstract] [Full Text] [Related]

  • 17. A primer for predicting risk of disease in HFE-linked hemochromatosis.
    Adams PC, Walker AP, Acton RT.
    Genet Test; 2001 May 10; 5(4):311-6. PubMed ID: 11960576
    [Abstract] [Full Text] [Related]

  • 18. Iron status and HFE mutations in first-degree relatives of patients with sporadic porphyria cutanea tarda, in a Mediterranean area.
    Garcia-Morillo JS, Lorca RR, Bernabeu-Wittel M, Garcia-Junco PS, Andreu EP, de la Fuente JC.
    J Intern Med; 2005 Apr 10; 257(4):389-90; author reply 391-3. PubMed ID: 15788010
    [No Abstract] [Full Text] [Related]

  • 19. Dual diagnoses of hereditary hyperferritinaemia-cataract syndrome and hereditary haemochromatosis.
    Hughes M, Vosylius P.
    Clin Lab Haematol; 2006 Oct 10; 28(5):357-9. PubMed ID: 16999731
    [Abstract] [Full Text] [Related]

  • 20. Correlation between genotype and phenotype in hereditary hemochromatosis: analysis of 61 cases.
    Sham RL, Ou CY, Cappuccio J, Braggins C, Dunnigan K, Phatak PD.
    Blood Cells Mol Dis; 1997 Aug 10; 23(2):314-20. PubMed ID: 9410475
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.